Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06536452 · ClinicalTrials.gov registry record

Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects

A clinical trial of Chronic Lymphocytic Leukemia and Monoclonal B-Cell Lymphocytosis, sponsored by Mayo Clinic.

Recruiting
Registry status
50
Enrollment target
1
Study location

NCT06536452: Recruiting study of Chronic Lymphocytic Leukemia and Monoclonal B-Cell Lymphocytosis, sponsored by Mayo Clinic.

NCT06536452 is a study of Chronic Lymphocytic Leukemia and Monoclonal B-Cell Lymphocytosis that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 50 participants, below the 182-participant average among 187 other Chronic Lymphocytic Leukemia trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06536452, a study of Chronic Lymphocytic Leukemia and Monoclonal B-Cell Lymphocytosis, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

This study evaluates hematopoiesis to determine how MBL/CLL affected bone marrow responds to fight off infections in the body.

Primary Outcome

Samples collected from healthy participants and participants with MBL will be compared for differences in bone marrow function (i.e., ability to fight off infection). Results will be descriptive. With participant permission, samples will be stored for future research use.

Conditions Studied

Chronic Lymphocytic Leukemia Monoclonal B-Cell Lymphocytosis

Interventions

  • OTHER Non-Interventional Study

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2016-11-18
Est. Completion 2026-11-18
Mayo Clinic

2,844 total trials

What NCT06536452 shows while recruiting

NCT06536452 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 182-participant average among 187 other Chronic Lymphocytic Leukemia trials with a reported enrollment target (73% lower).

The record links to 2 conditions, with Chronic Lymphocytic Leukemia appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.

NCT06536452 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06536452 about?

NCT06536452 is a clinical study titled "Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects". This study evaluates hematopoiesis to determine how MBL/CLL affected bone marrow responds to fight off infections in the body.

What is the current status of trial NCT06536452?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2016-11-18. Estimated completion is 2026-11-18.

What conditions does trial NCT06536452 study?

This clinical trial studies the following conditions: Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis.

What interventions are being tested in trial NCT06536452?

The interventions under investigation include: Non-Interventional Study (OTHER).

Who is sponsoring clinical trial NCT06536452?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06536452 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Lymphocytic Leukemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06536452's enrollment target sits among peer trials

50 101st of 187 higher than 83 of 187 other Chronic Lymphocytic Leukemia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Lymphocytic Leukemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06536452

Source: ClinicalTrials.gov NCT06536452, the US trial registry maintained by the National Library of Medicine. NCT06536452 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.